Evidence map›Paper›PMID 42681363›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Identification of Protein Cysteine Modifications Using Unbiased Mass Spectrometry-Based Proteomics.

Mark Schreuder, Mark Larance

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark SchreuderSchool of Life Sciences, University of Technology Sydney and Centenary Institute, University of Sydney, Sydney, NSW, Australia.
Mark LaranceCharles Perkins Centre and School of Medical Sciences, The University of Sydney, Sydney, Australia. mark.larance@sydney.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications (PTMs) can play vital roles in the protein's structure, function, localization, and interactions, enabling dynamic control of cellular processes. As such, understanding these modifications is essential to elucidate key biological mechanisms. This chapter discusses an unbiased, mass spectrometry-based approach using wildcard (open) searches in the Byonic platform to detect and identify nondisulfide cysteine PTMs. By targeting individual cysteines and scanning for mass shifts across a broad range, this strategy enables discovery of novel or unexpected modifications. The method is applicable to both new and existing datasets and can be extended to any amino acid, offering a versatile tool for redox and PTM-focused proteomics.

Indexed as

CysteineMass SpectrometryProtein Processing, Post-TranslationalProteinsProteomicsHumansCysteineProteinsByonicCysteineMass spectrometryPost-translational modificationsProthrombin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.